Loading clinical trials...
Loading clinical trials...
Resistell Phenotech AST to Determine the Antibiotic Susceptibility of Gram-negative Bacteria Causing Bacteremia: a Prospective, Non-interventional, Multi-centric, Clinical Performance Study
Conditions
Interventions
Resistell Phenotech
Locations
3
Austria
Medizinische Universität Innsbruck (MUI), Institut für Hygiene und Medizinische Mikrobiologie
Innsbruck, Innsbruck, Austria
Hospital Universitario Ramón y Cajal, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS)
Madrid, Madrid, Spain
Centre hospitalier universitaire vaudois (CHUV), Institut de Microbiologie
Lausanne, Lausanne, Switzerland
Start Date
January 18, 2023
Primary Completion Date
September 5, 2024
Completion Date
September 5, 2024
Last Updated
October 26, 2024
NCT06970899
NCT06853301
NCT03611257
NCT03577366
Lead Sponsor
Resistell AG
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions